Mucormycosis classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 8: Line 8:
==Classification==
==Classification==
Mucormycosis may be classified based on the [[organ system]] involvement as follows:
Mucormycosis may be classified based on the [[organ system]] involvement as follows:
{| class="wikitable"
!Type
!Transmission
!Signs and Symptoms
!Complications
|-
|Rhinocerebral mucormycosis
|
* Rhinocerebral mucormycosis is by far the most common form of the disease. It occurs most commonly in debilitated patients (specially those presenting with [[diabetic ketoacidosis]]) <ref name="urlRhinocerebral mucormycosis: Predisposing factors - Mcnulty - 1982 - The Laryngoscope - Wiley Online Library" /> and those undergoing [[hematopoietic stem cell]] [[transplantation]]. <ref name="urlEpidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients | Clinical Infectious Diseases | Oxford Academic">{{cite web |url=https://academic.oup.com/cid/article/34/7/909/316117/Epidemiology-and-Outcome-of-Mould-Infections-in |title=Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients &#124; Clinical Infectious Diseases &#124; Oxford Academic |format= |work= |accessdate=}}</ref>
*
|
* [[eye]] or [[facial]] pain
* [[facial]] [[numbness]]
* Facial ulceration and necrosis
* [[conjunctival injection]]
* [[Blurred vision|Blurry vision]]
* [[soft tissue]] [[swelling]]. <ref name="pmid14723256">{{cite journal |vauthors=Khor BS, Lee MH, Leu HS, Liu JW |title=Rhinocerebral mucormycosis in Taiwan |journal=J Microbiol Immunol Infect |volume=36 |issue=4 |pages=266–9 |year=2003 |pmid=14723256 |doi= |url=}}</ref> <ref name="urlRhinocerebral Mucormycosis: Evolution of the Disease and Treatment Options - Peterson - 1997 - The Laryngoscope - Wiley Online Library">{{cite web |url=http://onlinelibrary.wiley.com/doi/10.1097/00005537-199707000-00004/full |title=Rhinocerebral Mucormycosis: Evolution of the Disease and Treatment Options - Peterson - 1997 - The Laryngoscope - Wiley Online Library |format= |work= |accessdate=}}</ref>
* [[bilateral]] [[proptosis]]
* [[chemosis]]
* [[vision loss]]
* [[ophthalmoplegia]]
* [[cavernous sinus thrombosis]]
* Bloody [[nasal discharge]] may be the first sign that [[infection]] has invaded through the [[turbinates]] and into the [[brain]]
|
* Mycotic aneurysms
|-
|Pulmonary mucormycosis
|
|
|
|-
|Cutaneous mucormycosis
|
|
|
|-
|Gastrointestinal mucormycosis
|
|
|
|-
|Disseminated mucormycosis
|
|
|
|}


===Rhinocerebral mucormycosis===
===Rhinocerebral mucormycosis===
* Rhinocerebral mucormycosis is by far the most common form of the disease. It occurs most commonly in debilitated patients (specially those presenting with [[diabetic ketoacidosis]]). <ref name="urlRhinocerebral mucormycosis: Predisposing factors - Mcnulty - 1982 - The Laryngoscope - Wiley Online Library">{{cite web |url=http://onlinelibrary.wiley.com/doi/10.1288/00005537-198910000-00006/full |title=Rhinocerebral mucormycosis: Predisposing factors - Mcnulty - 1982 - The Laryngoscope - Wiley Online Library |format= |work= |accessdate=}}</ref>  
* Rhinocerebral mucormycosis is by far the most common form of the disease. It occurs most commonly in debilitated patients (specially those presenting with [[diabetic ketoacidosis]]). <ref name="urlRhinocerebral mucormycosis: Predisposing factors - Mcnulty - 1982 - The Laryngoscope - Wiley Online Library">{{cite web |url=http://onlinelibrary.wiley.com/doi/10.1288/00005537-198910000-00006/full |title=Rhinocerebral mucormycosis: Predisposing factors - Mcnulty - 1982 - The Laryngoscope - Wiley Online Library |format= |work= |accessdate=}}</ref>  
* Another patient population that has been found to be susceptible to mucormycosis are those undergoing [[hematopoietic stem cell]] [[transplantation]]. <ref name="urlEpidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients | Clinical Infectious Diseases | Oxford Academic">{{cite web |url=https://academic.oup.com/cid/article/34/7/909/316117/Epidemiology-and-Outcome-of-Mould-Infections-in |title=Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients &#124; Clinical Infectious Diseases &#124; Oxford Academic |format= |work= |accessdate=}}</ref>
* Another patient population that has been found to be susceptible to mucormycosis are  
* Initial symptoms include [[eye]] or [[facial]] pain and [[facial]] [[numbness]], followed by the onset of [[conjunctival injection]], [[Blurred vision|blurry vision]], and [[soft tissue]] [[swelling]]. <ref name="pmid14723256">{{cite journal |vauthors=Khor BS, Lee MH, Leu HS, Liu JW |title=Rhinocerebral mucormycosis in Taiwan |journal=J Microbiol Immunol Infect |volume=36 |issue=4 |pages=266–9 |year=2003 |pmid=14723256 |doi= |url=}}</ref> <ref name="urlRhinocerebral Mucormycosis: Evolution of the Disease and Treatment Options - Peterson - 1997 - The Laryngoscope - Wiley Online Library">{{cite web |url=http://onlinelibrary.wiley.com/doi/10.1097/00005537-199707000-00004/full |title=Rhinocerebral Mucormycosis: Evolution of the Disease and Treatment Options - Peterson - 1997 - The Laryngoscope - Wiley Online Library |format= |work= |accessdate=}}</ref>
* Initial symptoms include  
* If untreated, [[infection]] usually spreads from the [[ethmoid sinus]] to the orbit, resulting in loss of [[Extraocular muscles|extraocular muscle]] function and [[proptosis]].
* If untreated, [[infection]] usually spreads from the [[ethmoid sinus]] to the orbit, resulting in loss of [[Extraocular muscles|extraocular muscle]] function and [[proptosis]].
* The [[infection]] may rapidly spread into the neighboring tissues.  
* The [[infection]] may rapidly spread into the neighboring tissues.  
* Onset of signs and symptoms in the [[contralateral]] eye, with resulting [[bilateral]] [[proptosis]], [[chemosis]], [[vision loss]], and [[ophthalmoplegia]], is a sign that suggests the development of [[cavernous sinus thrombosis]].  
* Onset of signs and symptoms in the [[contralateral]] eye, with resulting is a sign that suggests the development of.  
* [[Infection]] can also spread [[Posterior|posteriorly]] from either the [[Orbit (anatomy)|orbit]] or [[sinuses]] to the [[central nervous system]].  
* [[Infection]] can also spread [[Posterior|posteriorly]] from either the [[Orbit (anatomy)|orbit]] or [[sinuses]] to the [[central nervous system]].  
* A bloody [[nasal discharge]] may be the first sign that [[infection]] has invaded through the [[turbinates]] and into the [[brain]].  
* A.  
* Hematogenous spread may lead to development of [[mycotic]] [[Aneurysm|aneurysms]].
* Hematogenous spread may lead to development of [[mycotic]] [[Aneurysm|aneurysms]].



Revision as of 23:53, 18 June 2017

Mucormycosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mucormycosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Overview

Mucormycosis may be classified according to the organ system involved including brain, lungs, skin, GIT, bones, liver, spleen. Disseminated infection affects multiple organ systems and is associated with high mortality.

Classification

Mucormycosis may be classified based on the organ system involvement as follows:

Type Transmission Signs and Symptoms Complications
Rhinocerebral mucormycosis
  • Mycotic aneurysms
Pulmonary mucormycosis
Cutaneous mucormycosis
Gastrointestinal mucormycosis
Disseminated mucormycosis

Rhinocerebral mucormycosis

Pulmonary mucormycosis

Cutaneous mucormycosis

Gastrointestinal mucormycosis

Disseminated mucormycosis

References

  1. 1.0 1.1 "Rhinocerebral mucormycosis: Predisposing factors - Mcnulty - 1982 - The Laryngoscope - Wiley Online Library".
  2. "Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients | Clinical Infectious Diseases | Oxford Academic".
  3. Khor BS, Lee MH, Leu HS, Liu JW (2003). "Rhinocerebral mucormycosis in Taiwan". J Microbiol Immunol Infect. 36 (4): 266–9. PMID 14723256.
  4. "Rhinocerebral Mucormycosis: Evolution of the Disease and Treatment Options - Peterson - 1997 - The Laryngoscope - Wiley Online Library".
  5. Morrison VA, McGlave PB (1993). "Mucormycosis in the BMT population". Bone Marrow Transplant. 11 (5): 383–8. PMID 8504272.
  6. Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE (1994). "Pulmonary mucormycosis: results of medical and surgical therapy". Ann. Thorac. Surg. 57 (4): 1044–50. PMID 8166512.
  7. "Improved Outcome of Zygomycosis in Patients with Hematological Diseases?: Leukemia & Lymphoma: Vol 45, No 7".
  8. "Cutaneous Rhizopus Infection | JAMA | The JAMA Network".
  9. "Gangrenous Cutaneous Mucormycosis in a Child with a Solid Organ Transplant: A Case Report and Review of the Literature - Boyd - 2003 - Pediatric Dermatology - Wiley Online Library".
  10. "www.nature.com" (PDF).
  11. "GASTRIC PERFORATION DUE TO MUCORMYCOSIS AFTER HEART-LUNG AND... : Transplantation".
  12. STRAATSMA BR, ZIMMERMAN LE, GASS JD (1962). "Phycomycosis. A clinicopathologic study of fifty-one cases". Lab. Invest. 11: 963–85. PMID 13984484.
  13. "Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole? - Ide - 2004 - Clinical Microbiology and Infection - Wiley Online Library".
  14. "Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole | Clinical Infectious Diseases | Oxford Academic".

Template:WH Template:WS